LCM
ORTX

Laurion Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Laurion Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,672
Closed -$793K – 1309
2019
Q3 		$793K Sell
6,672
-10,412
-61% -$1.45M 0.01% 683
2019
Q2 		$2.39M Buy
+17,084
New +$3M 0.02% 357

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Laurion Capital Management's ORTX Position: Q4 2019 in Review

Laurion Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2019, closing a stake of 6,672 shares — an estimated $793K sold.

Laurion Capital Management first reported a position in ORTX in Q2 2019 and held it in 2 quarters. The position peaked at $2.39M in Q2 2019. 81 funds tracked by Wall St. Rank hold ORTX as of Q4 2019.

  • Laurion Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Laurion Capital Management sold 6,672 Orchard Therapeutics plc American Depositary Shares shares in Q4 2019, an estimated $793K.
  • Laurion Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 2 quarters.
  • Laurion Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $2.39M in Q2 2019.
  • 81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2019.

Based on Laurion Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.